MCB 2010 LTD
Business Summary
Develops biotechnology products. The Company develops new regenerative medicine technologies for the treatment of tendon and ligament injuries. MedCell Biosciences primary technologies utilize adult mesenchymal stem cells in the treatment of tendinitis, tendinosis and desmitis in conditions such as rotator cuff injuries (RCIs) and Achilles tendinopathies. The Companys technologies include MS-ten, Stem Cell Bio-Processing, NovaPod, and TheraGlass. The Company supplies products to UK and mainland Europe, US, Australia, South America and Middle East. The Company was founded in 2002 and is headquartered in Cambridge, United Kingdom.
Country of Incorporation
-
Incorporation Date
2002-08-22
Business Sector
Pharmaceuticals & Medical Research
Company Address
-
Get access to the below data and more business development tools by signing up for the MENA Company Data product.
- Ownership details
- Corporate structure
- Business classification
- Officers & Directors contact details
- Full company contact details
Multiply your reach by contributing your content to LSEG
LSEG contributed content reaches tens of thousands of buy and sell side professionals around the world through an integrated suite of market intelligence and transaction platforms.NEWS ON THIS COMPANY
TOP PICKS
MOST READ
MOST WATCHED
MOST POPULAR
1.
2.
3.
4.
5.
